Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05957536 |
Title | A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | D3 Bio (Wuxi) Co., Ltd |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
D3 Bio Investigative Site | RECRUITING | Stanford | California | 94305 | United States | Details |
D3 Bio Investigative Site | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
D3 Bio Investigative Site | RECRUITING | New York | New York | 10065 | United States | Details |
D3 Bio Investigative Site | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
D3 Bio Investigative Site | RECRUITING | Sydney | New South Wales | 2109 | Australia | Details |
D3 Bio Investigative Site | RECRUITING | Malvern | Victoria | 3144 | Australia | Details |
D3 Bio Investigative Site | RECRUITING | Harbin | Heilongjiang | 150088 | China | Details |
D3 Bio Investigative Site | RECRUITING | Shanghai | Shanghai | 200025 | China | Details |
D3 Bio Investigative Site | RECRUITING | Hangzhou | Zhejiang | 310022 | China | Details |